SM
PBYI icon

Sabby Management’s Puma Biotechnology PBYI Stock Holding History

Sabby Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,600
Closed -$394K – 248
2017
Q1 		$394K Sell
10,600
-92,643
-90% -$3.38M 0.02% 192
2016
Q4 		$3.17M Buy
+103,243
New +$4.46M 0.18% 75
2015
Q4 		– Sell
-26,704
Closed -$2.01M – 353
2015
Q3 		$2.01M Buy
+26,704
New +$2.53M 0.08% 156
2015
Q2 		– Sell
-9,044
Closed -$1.64M – 350
2015
Q1 		$2.13M Sell
9,044
-9,816
-52% -$2.1M 0.09% 140
2014
Q4 		$3.57M Buy
+18,860
New +$4.18M 0.11% 86

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sabby Management's PBYI Position: Q2 2017 in Review

Sabby Management sold out of Puma Biotechnology (PBYI) in Q2 2017, closing a stake of 10,600 shares — an estimated $394K sold.

Sabby Management first reported a position in PBYI in Q4 2014 and held it in 5 quarters. The position peaked at $3.57M in Q4 2014. 154 funds tracked by Wall St. Rank hold PBYI as of Q2 2017.

  • Sabby Management reported no remaining Puma Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Sabby Management sold 10,600 Puma Biotechnology shares in Q2 2017, an estimated $394K.
  • Sabby Management first reported a position in Puma Biotechnology in Q4 2014 and held it in 5 quarters.
  • Sabby Management's Puma Biotechnology position peaked at $3.57M in Q4 2014.
  • 154 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.